Dhruvitkumar S. Sutaria

1.4k citations
34 papers · 1.1k indexed · 1 hit paper · h-index 14

Dhruvitkumar S. Sutaria

30 papers receiving 1.1k citations

Hit Papers

Comprehensive toxicity and immunogenicity studies reveal ...4472017202620202023100200300400

Peers

Dhruvitkumar S. Sutaria
Comparison fields: 5 of 88
  • Cancer Research 426
  • Molecular Medicine 125
  • Molecular Biology 777
  • Applied Microbiology and Biotechnology 16
  • Pharmacology 90
Replace Yanbin Zhou with:
Yanbin Zhou China
Liang Zhu China
Gorjana Rackov Spain
Mary Ferguson United States
Maryam Tahmasebi Birgani Iran
Huan Shi China
Bingbing Qiao China
Alexandra Iulia Irimie Romania
Xinying Xue China
Dhruvitkumar S. Sutaria relative to Yanbin Zhou China Yanbin Zhou's profile →
Citations per field
00.5×
Yanbin Zhou · 1×
Citations per year

Countries citing papers authored by Dhruvitkumar S. Sutaria

Since Specialization
Citations

This map shows the geographic impact of Dhruvitkumar S. Sutaria's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dhruvitkumar S. Sutaria with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dhruvitkumar S. Sutaria more than expected).

Fields of papers citing papers by Dhruvitkumar S. Sutaria

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dhruvitkumar S. Sutaria. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dhruvitkumar S. Sutaria. The network helps show where Dhruvitkumar S. Sutaria may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Dhruvitkumar S. Sutaria, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dhruvitkumar S. Sutaria Line = papers co-authored together Dhruvitkumar S. Sutaria links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20243
3 20244
4 20240
5 20235
6 20224
7 20227
8 202017
9 201921
10 201911
11 20195
12 201860
13 20188
14 2017113
15 201718
16 201622
17 201639
18 201329
19 201256
20 201120

About Dhruvitkumar S. Sutaria

Dhruvitkumar S. Sutaria is a scholar working on Molecular Medicine, Cancer Research and Toxicology, having authored 34 papers that have together received 1.1k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (9 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotics Pharmacokinetics and Efficacy (8 papers), Extracellular vesicles in disease (4 papers), RNA Interference and Gene Delivery (4 papers), RNA modifications and cancer (4 papers), Prostate Cancer Treatment and Research (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Cancer Research (426 citations), Molecular Medicine (125 citations) and Molecular Biology (777 citations). Dhruvitkumar S. Sutaria has collaborated with scholars based in United States, Australia and South Korea. Frequent co-authors include Thomas D. Schmittgen, Mohamed Badawi, Mitch A. Phelps, Jinmai Jiang, Ola A. Elgamal, Jeffrey J. Chalmers, Xiaohua Zhu, Steven Pomeroy, Xiaokui Mo and Alice Baek.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026